RANI today
$0.53-$0.04 (-7.54%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourExpanding
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns down below $0.39
Key levels
Resistance$0.63
Resistance$0.57
Support$0.51
Support$0.45
Latest news & SEC filings
SEC FilingRani Therapeutics Holdings, Inc. filed a report on a major company event (Form 8-K)
EarningsRani Therapeutics Posts Q3 2026 Results
All RANI news →About Rani Therapeutics
Rani Therapeutics is a clinical-stage biotherapeutics company developing oral delivery technology for biologics and drugs. Its main platform is the RaniPill capsule, with two versions: RaniPill GO and RaniPill HC, designed to deliver antibodies, proteins, peptides, and oligonucleotides orally instead of by injection. The company is developing its own product candidates, including RT-114 for obesity, and partners with biopharmaceutical companies to apply its technology to their drugs. It operates in the United States and conducts clinical trials internationally.
Based on the company's 10-K filed Mar 26, 2026.
Nasdaq · Healthcare
Rani Therapeutics Holdings, Inc. (RANI)
What Is the Price Target for RANI?
SEPT Low Target
$5.00
SEPT Mid Target
$5.00
SEPT High Target
$5.00
Analyst Consensus
$5.00
Is RANI a Buy or Sell Right Now?
Thesis
- •Revenue growing 58.9% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for RANI.
Start Free Trial →Is RANI Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$3.88
22
Moat Score
NONE
4/9
Piotroski Score
-4.5
Altman Z-Score
What Is Smart Money Doing with RANI?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Imran Talat | director officer | Sale | 7,928 | $6K | Sep 27, 2026 |
| Javadi Alireza | officer | Sale | 309 | $234.59 | Sep 27, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →RANI Growth Story
Revenue YoY
58.9%
3yr Revenue CAGR
N/A%
EPS Growth YoY
57.14%
FCF Growth YoY
47.4%
Revenue Trend
ACCELERATING
Dark Pool Trades for RANI
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for RANI, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:58:05 | $0.53 | 5,000 | $$3K | SELL |
| 20:55:25 | $0.53 | 5,000 | $$3K | BUY |
| 20:39:36 | $0.53 | 12,800 | $$7K | BUY |
| 20:34:36 | $0.52 | 1,000 | $$521 | SELL |
| 20:32:10 | $0.53 | 1,852 | $$973 | SELL |
5 dark pool trades shown · $$14K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Rani Therapeutics Holdings, Inc. (RANI) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →RANI — frequently asked questions
What is RANI stock price today?
Rani Therapeutics Holdings, Inc. (RANI) is at $0.53, down 7.54% (-$0.04) at the Nov 12, 2026 close.
Why is RANI stock moving today?
Latest RANI news — Nov 12, 2026: Rani Therapeutics Holdings, Inc. filed a report on a major company event (Form 8-K) · Nov 10, 2026: Rani Therapeutics Posts Q3 2026 Results
What is the RANI price target?
The average analyst price target for RANI is $5.00, ranging from $5 to $5, based on 1 analysts. Latest: Canaccord Genuity maintains on Apr 1, 2026.
What do analysts rate RANI?
Analyst ratings for RANI: 0 Buy, 4 Hold, 0 Sell — consensus Hold.
Did RANI beat earnings?
RANI last reported on Aug 13, 2026: EPS -$0.04 vs -$0.05 expected — a beat of 20.0%.
Does RANI pay a dividend?
RANI does not currently pay a dividend.
What are RANI support and resistance levels?
Support: $0.51, $0.45, $0.39. Resistance: $0.57, $0.63, $0.68.
What are insiders doing with RANI?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on RANI?
Nov 12, 2026: Rani Therapeutics Holdings, Inc. filed a report on a major company event (Form 8-K) · Nov 10, 2026: Rani Therapeutics Posts Q3 2026 Results